APA

Dombernowsky P., Nissen N. I. & Larsen V. (19720807). Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. : Cancer chemotherapy reports.

Chicago

Dombernowsky P, Nissen N I and Larsen V. 19720807. Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. : Cancer chemotherapy reports.

Harvard

Dombernowsky P., Nissen N. I. and Larsen V. (19720807). Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. : Cancer chemotherapy reports.

MLA

Dombernowsky P, Nissen N I and Larsen V. Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. : Cancer chemotherapy reports. 19720807.